Small-Cap Growth Stocks: On a Roll With Room to Run

Do these small-cap growth stocks with double-digit gains interest you? See what there is to like about Kodiak Oil & Gas Corporation, The Middleby Corporation, and Isis Pharmaceuticals.

Apr 29, 2014 at 5:17PM

Exchange-traded funds offer a convenient way to invest in sectors or niches that interest you. If you'd like to add some small-cap growth stocks to your portfolio but don't have the time or expertise to hand-pick a few, the Vanguard Russell 2000 Growth Index ETF (NYSEMKT: VTWG) could save you a lot of trouble. Instead of trying to figure out which stocks will perform best, you can use this ETF to invest in lots of small-cap growth stocks simultaneously.

The basics
ETFs often sport lower expense ratios than their mutual fund cousins. This ETF, focused on small-cap growth stocks, sports a relatively low expense ratio -- an annual fee -- of 0.20%. The fund is fairly small, so if you're thinking of buying, beware of possibly large spreads between its bid and ask prices. Consider using a limit order if you want to buy in.

This small-cap growth stocks ETF has underperformed the S&P 500 over the past three years, but it topped its large-cap counterpart handily in 2013. As with most investments, of course, we can't expect outstanding performances in every quarter or year. Investors with conviction need to wait for their holdings to deliver.

Why small-cap growth stocks?
It's smart to include smaller-company stocks in your portfolio, as the best of these companies can grow rapidly and eventually become large caps. This ETF, focused on small-cap growth stocks, contains components of the Russell 2000 index of small-cap stocks (some of which can be considered mid-caps) that have been growing at a brisk pace.

Lots of small-cap growth stocks had strong performances over the past year. Questcor Pharmaceuticals (NASDAQ:QCOR), for instance, surged 171%, in part on surprising news that it's being bought out by Mallinckrodt for $5.6 billion. Questcor is largely known for its multiple-sclerosis drug Acthar, which has been approved for 19 indications. Some worry that all of Questcor's eggs are in that one basket. On top of that, the company is being investigated for how it has marketed Acthar.

Kodiak Oil & Gas Corporation (NYSE:KOG) has recently been trading about 74% above its 52-week low. It's a top operator in the promising Bakken Shale region, and has been boosting its production aggressively, thanks to fracking and other methods. Kodiak Oil & Gas has been boosting production while cutting costs, but some worry about whether North Dakota's proposed slowing of production will hurt Bakken operators. They worry about Kodiak's significant debt load, too.

Other small-cap growth stocks didn't do quite so well over the last year but could see their fortunes change in the coming years. Isis Pharmaceuticals, (NASDAQ:IONS) advanced a solid 40% over the past 12 months. The specialist in orphan drugs has fallen in recent months, with some seeing it as overvalued given its single approved drug, the cholesterol-fighting Kynamro. Still, many are willing to pay up for its shares on the basis of its rich pipeline, which holds a lot of potential, not all of which is likely to be realized. Isis has partnered with lots of bigger pharmaceutical companies, which gives it access to funding but also means it must fork over a portion of profits.

The big picture
If you're interested in adding some small-cap growth stocks to your portfolio, consider doing so via an ETF. A well-chosen ETF can grant you instant diversification across any industry or group of companies -- and make investing in and profiting from it that much easier.

Will this stock be your next multi-bagger?
Give me five minutes and I'll show how you could own the best stock for 2014. Every year, The Motley Fool's chief investment officer hand-picks 1 stock with outstanding potential. But it's not just any run-of-the-mill company. It's a stock perfectly positioned to cash in on one of the upcoming year's most lucrative trends. Last year his pick skyrocketed 134%. And previous top picks have gained upwards of 908%, 1,252% and 1,303% over the subsequent years! Believe me, you don't want to miss what could be his biggest winner yet! Just click here to download your free copy of "The Motley Fool's Top Stock for 2014" today.

Selena Maranjian owns shares of Isis Pharmaceuticals and Questcor Pharmaceuticals. The Motley Fool recommends Isis Pharmaceuticals. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.

1 Key Step to Get Rich

Our mission at The Motley Fool is to help the world invest better. Whether that’s helping people overcome their fear of stocks all the way to offering clear and successful guidance on complicated-sounding options trades, we can help.

Feb 1, 2016 at 4:54PM

To be perfectly clear, this is not a get-rich action that my Foolish colleagues and I came up with. But we wouldn't argue with the approach.

A 2015 Business Insider article titled, "11 websites to bookmark if you want to get rich" rated The Motley Fool as the #1 place online to get smarter about investing.

"The Motley Fool aims to build a strong investment community, which it does by providing a variety of resources: the website, books, a newspaper column, a radio [show], and [newsletters]," wrote (the clearly insightful and talented) money reporter Kathleen Elkins. "This site has something for every type of investor, from basic lessons for beginners to investing commentary on mutual funds, stock sectors, and value for the more advanced."

Our mission at The Motley Fool is to help the world invest better, so it's nice to receive that kind of recognition. It lets us know we're doing our job.

Whether that's helping the entirely uninitiated overcome their fear of stocks all the way to offering clear and successful guidance on complicated-sounding options trades, we want to provide our readers with a boost to the next step on their journey to financial independence.

Articles and beyond

As Business Insider wrote, there are a number of resources available from the Fool for investors of all levels and styles.

In addition to the dozens of free articles we publish every day on our website, I want to highlight two must-see spots in your tour of fool.com.

For the beginning investor

Investing can seem like a Big Deal to those who have yet to buy their first stock. Many investment professionals try to infuse the conversation with jargon in order to deter individual investors from tackling it on their own (and to justify their often sky-high fees).

But the individual investor can beat the market. The real secret to investing is that it doesn't take tons of money, endless hours, or super-secret formulas that only experts possess.

That's why we created a best-selling guide that walks investors-to-be through everything they need to know to get started. And because we're so dedicated to our mission, we've made that available for free.

If you're just starting out (or want to help out someone who is), go to www.fool.com/beginners, drop in your email address, and you'll be able to instantly access the quick-read guide ... for free.

For the listener

Whether it's on the stationary exercise bike or during my daily commute, I spend a lot of time going nowhere. But I've found a way to make that time benefit me.

The Motley Fool offers five podcasts that I refer to as "binge-worthy financial information."

Motley Fool Money features a team of our analysts discussing the week's top business and investing stories, interviews, and an inside look at the stocks on our radar. It's also featured on several dozen radio stations across the country.

The hosts of Motley Fool Answers challenge the conventional wisdom on life's biggest financial issues to reveal what you really need to know to make smart money moves.

David Gardner, co-founder of The Motley Fool, is among the most respected and trusted sources on investing. And he's the host of Rule Breaker Investing, in which he shares his insights into today's most innovative and disruptive companies ... and how to profit from them.

Market Foolery is our daily look at stocks in the news, as well as the top business and investing stories.

And Industry Focus offers a deeper dive into a specific industry and the stories making headlines. Healthcare, technology, energy, consumer goods, and other industries take turns in the spotlight.

They're all informative, entertaining, and eminently listenable ... and I don't say that simply because the hosts all sit within a Nerf-gun shot of my desk. Rule Breaker Investing and Answers contain timeless advice, so you might want to go back to the beginning with those. The other three take their cues from the market, so you'll want to listen to the most recent first. All are available at www.fool.com/podcasts.

But wait, there's more

The book and the podcasts – both free ... both awesome – also come with an ongoing benefit. If you download the book, or if you enter your email address in the magical box at the podcasts page, you'll get ongoing market coverage sent straight to your inbox.

Investor Insights is valuable and enjoyable coverage of everything from macroeconomic events to investing strategies to our analyst's travels around the world to find the next big thing. Also free.

Get the book. Listen to a podcast. Sign up for Investor Insights. I'm not saying that any of those things will make you rich ... but Business Insider seems to think so.


Compare Brokers